Horizon Surgical Systems, Inc. is a medical robotics company founded in 2021 and focused on surgical technology for ophthalmology. Its core product, Polaris™, is a surgical platform that combines AI-driven visualization with micro-robotic control, designed specifically for eye surgery. The company claims Polaris™ is the world's first AI-supported and robotics-enabled surgical platform purpose-built for ophthalmology.
Horizon completed a first-in-human study involving 10 patients and, in October, announced what it describes as the world's first robotic-assisted cataract surgery - a milestone the company attributes to the Polaris™ platform. The system is designed to deliver greater precision, consistency, and safety in ophthalmic procedures. Horizon was founded by experts in ophthalmology and medical robotics and has raised $30 million in Series A funding.
The company operates at the intersection of surgical robotics, AI, and microsurgery, with a stated mission to improve outcomes for patients requiring eye surgery worldwide.
